NCT00918346View on ClinicalTrials.gov

Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

April 30, 2006

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Tafluprost 0.0015%

Eye drops, 0.015 mg/ml, once daily to affected eye(s)

Trial Locations (3)

82319

Praxis Dr. Hamacher, Starnberg

90029

Oulu University Hospital, Oulu

93059

Ulrich Richter's surgery, Regensburg

All Listed Sponsors
lead

Santen Oy

INDUSTRY

NCT00918346 - Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation | Biotech Hunter | Biotech Hunter